Skip to main content
Signal8

Squadron Capital Management LLC

Squadron Capital Management LLC is an Investment Adviser institutional filer with the SEC under CIK 2050709, reporting 34 portfolio positions, with 9 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Squadron Capital Management LLC's most recent 13F filing, ranked by reported market value.

  1. RELMADA THERAPEUTICS INC (RLMD)
  2. C4 THERAPEUTICS INC (CCCC)
  3. COGENT BIOSCIENCES INC (COGT)
  4. KODIAK SCIENCES INC (KOD)
  5. RELAY THERAPEUTICS INC (RLAY)
  6. ZENTALIS PHARMACEUTICALS INC (ZNTL)
  7. EDGEWISE THERAPEUTICS INC (EWTX)
  8. MAZE THERAPEUTICS INC (MAZE)
  9. INVENTIVA SA (IVA)
  10. ADLAI NORTYE LTD (ANL)
/